Visual Abstract: Effectiveness of Inhaled Ciclesonide for Outpatient Treatment of Adolescents, Adults With Symptomatic COVID-19

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, NOVEMBER 22, 2021

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2021.6759?guestAccessKey=4708e2de-05bb-42dc-bfef-f5db9f9b39ba&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112221

 

Visual Abstract

 

Authors: Brian M. Clemency, D.O., of the University at Buffalo in New York, is the corresponding author.

(doi:10.1001/jamainternmed.2021.6759)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.